VITEK MS MALDI-TOF Mass Spectrometry System for pathogen identification has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded identification of mycobacteria, Nocardia and molds. The database update also includes important clinical pathogens such as Brucella species, Candida auris, and Elizabethkingia anophelis. The VITEK MS database includes more than 15,000 distinct strains to provide highly accurate identifications of these difficult to cultivate and difficult to identify organisms.
Reagent kits have been introduced; the VITEK MS Mycobacterium/Nocardia Kits1 and the VITEK MS Mold Kit.2 These reagent kits enable simple and safe inactivation and protein extraction of these organisms.
The Mycobacterium/Nocardia Kits are FDA 510(k) cleared for extraction from both solid and liquid medium. The Mold Kit is FDA 510(k) cleared for extraction from solid medium.
bioMérieux’s VITEK MS system offers simple and reliable identification of medically important pathogens, providing clinicians with actionable results to better manage serious infections.
For more information, please contact your local bioMérieux representative or visit www.biomerieux-usa.com/vitek-ms.
 |
 |
 |
 |
| Mold Flyer | Mycobacteria Flyer | VITEK MS V3.2 Flyer | Total Identification Solution Flyer |
|
NEW VITEK PICKME™ for VITEK MS |
References:
1. REF 415659 VITEK® MS MYCOBACTRIUM/NOCARDIA KIT & REF 421564 VITEK® MS LIQUID MYCO SUPPLEMENTAL KIT
2. REF 415680 VITEK® MS MOULD KIT